Kuraray Noritake Dental

Japan · www.kuraraynoritake.com · 2 vendors

Resilience scores

Technology vendors

Services catalogue

1 service in catalogue across 1 category; runs on 2 sub-vendors.

Insights

Last updated 2026-08-06 · revision 1

2 direct vendors, 29 subvendors

Direct vendors by controlling owner country (sample)

Subvendors by controlling owner country (sample)

Migration Readiness: 5/10

Assessed by AI based on technology stack characteristics (cloud-native vs legacy, containerization, microservices), regulatory environment, data residency requirements, financial stability, and vendor lock-in risks. The score ranges from 0-10, where higher scores indicate better readiness for technology migration.

Kuraray Noritake Dental's migration readiness is difficult to assess accurately due to significant data gaps, placing it in the lower-medium readiness category. The most critical challenge is the complete absence of data regarding the internal tech stack. Without knowing if the company utilizes legacy systems, monolithic architectures, or modern cloud-native, containerized, or microservices approaches, it is impossible to determine their technical readiness for migration. This is a fundamental unknown that severely impacts the assessment. Financial stability data (revenue concentration, growth history) is also missing, making it impossible to determine the company's capacity to fund a potentially significant migration effort. Vendor lock-in risk is unknown; while only 2 vendor services are reported, if these are deeply integrated and critical, they could pose substantial barriers to migration. The concentration of vendor ownership in the United States could also add complexity to contract renegotiations or transitions. Information on the regulatory environment is also missing, which could introduce unforeseen compliance hurdles during migration. On the positive side, the explicit statement 'Data Residency Requirements: Not specified' is a favorable indicator, suggesting a lack of strict data residency constraints, which offers greater flexibility for cloud adoption and choosing migration targets.

Compliance

9 in-scope frameworks identified; showing 3.

GDPR (source) — Assessment Required

Kuraray Noritake Dental is a global dental materials manufacturer with confirmed operations and distribution across the EU/EEA (including Germany, France, and other European markets). As a company headquartered in Japan that actively markets to and processes personal data of EU/EEA residents — including dental professionals, customers, and employees in European subsidiaries — GDPR applies with certainty. The risk level is High because: (1) non-compliance can result in fines up to €20M or 4% of global annual turnover; (2) the company operates across multiple EU jurisdictions, increasing the complexity of compliance; (3) as a B2B dental company, it processes professional contact data, purchasing data, and potentially health-adjacent data; (4) Japan-to-EU data transfers require an adequacy decision or appropriate safeguards (Japan has an EU adequacy decision since 2019, but internal transfer mechanisms must still be documented); (5) no public GDPR compliance documentation was found, raising uncertainty about the maturity of their compliance program.

Evidence: https://www.kuraraynoritake.com/, https://ec.europa.eu/commission/presscorner/detail/en/IP_19_421, https://gdpr-info.eu/, https://www.edpb.europa.eu/our-work-tools/general-guidance/gdpr-guidelines-recommendations-best-practices_en

APPI — Assessment Required

APPI is Japan's primary data protection law and directly applies to Kuraray Noritake Dental as a Japan-headquartered company. The 2022 amendments (effective April 2022) significantly strengthened APPI, bringing it closer to GDPR standards. The risk level is High because: (1) the company is headquartered in Japan and must comply with APPI for all personal data processing in Japan; (2) the 2022 amendments introduced mandatory breach notification, stricter cross-border transfer rules, and enhanced individual rights; (3) the Personal Information Protection Commission (PPC) has increased enforcement activity; (4) as a subsidiary of Kuraray Co., Ltd. (a major listed company), regulatory scrutiny is elevated.

Evidence: https://www.ppc.go.jp/en/, https://www.kuraraynoritake.com/

ISO 13485 — Assessment Required

ISO 13485 is the internationally recognized quality management standard for medical device manufacturers and is effectively mandatory for companies selling medical devices in the EU (required for CE marking under EU MDR) and strongly expected by regulatory bodies globally. Kuraray Noritake Dental, as a dental materials manufacturer, almost certainly operates under ISO 13485, but no certificate was confirmed in this research session. The risk level is High because: (1) ISO 13485 certification is a prerequisite for EU MDR conformity assessment; (2) loss of certification would result in inability to sell in major markets; (3) the standard requires comprehensive quality management across design, manufacturing, and post-market activities.

Evidence: https://www.iso.org/standard/59752.html, https://www.kuraraynoritake.com/

Financials

Three-year financials

Financial Resilience Score: 7/10

Kuraray Noritake Dental benefits from strong backing by two listed Japanese parents—Kuraray Co., Ltd. (approx. 70%) and Noritake Co., Limited (approx. 30%). Kuraray is a major TSE Prime Market specialty chemicals company with a diversified portfolio and solid investment-grade credit standing, providing financial and R&D support to the dental JV. This parent backing significantly enhances the subsidiary's resilience even without public stand-alone disclosure. The company holds technology leadership through Kuraray's industry-standard MDP monomer adhesive chemistry (used in Panavia and Clearfil products) and Noritake's respected dental ceramics IP (Katana Zirconia, Cerabien). Its portfolio of dental consumables generates recurring revenue from dental labs and clinicians globally in more than 70 countries. However, resilience is tempered by concentrated end-market exposure to dental clinic capital spending cycles (as evidenced by COVID-19 impacts in 2020), intense competition from larger players such as 3M/Solventum, Dentsply Sirona, Ivoclar Vivadent, GC Corporation, Kerr, and Envista, meaningful FX exposure from export revenue, and JV governance complexity inherent in dual-parent structures. Limited public disclosure also poses a transparency risk for external stakeholders.

Key strengths: Strong parent backing from Kuraray Co., Ltd. (TSE 3405), an investment-grade specialty chemicals company, Technology leadership via MDP monomer adhesive chemistry (Panavia, Clearfil), Noritake's respected dental ceramics IP (Katana Zirconia, Cerabien), Global brand portfolio sold in 70+ countries, Recurring consumables revenue from dental professionals

Risk factors: Limited public disclosure as a private JV creates governance/monitoring risk, Concentrated end-market exposure to dental clinic capital spending cycles, Intense competition from larger players (3M/Solventum, Dentsply Sirona, Ivoclar Vivadent, GC, Kerr, Envista), FX exposure from JPY/USD and JPY/EUR fluctuations on export revenue, JV governance complexity from dual-parent structure

Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.

View the full interactive report